• Halozyme Therapeutics average gross margin for 2023 was 77.14%, a 4.39% increase from 2022.
• Halozyme Therapeutics average gross margin for 2022 was 80.68%, a 1.63% decline from 2021.
• Halozyme Therapeutics average gross margin for 2021 was 82.02%, a 5.33% decline from 2020.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.